Abbott Laboratories Recent News
Short Interest In Abbott Labs And Baxter International Doubles
Mylan Is 'Comfortable Moving Forward' With Acquisition Of Sweden-Based Meda
5 Family-Friendly Employers For Working Parents
5 Top Dow Stocks With The Most Upside Potential
Market Wrap For April 21: S&P 500 Extends Winning Streak To Five Days, Dow & Nasdaq Also Positive
Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data
New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)
Earnings Expectations For The Week Of January 20: Microsoft, McDonald's, Netflix And More
UPDATE: Goldman Sachs Upgrades Abbott Laboratories; Growth Is Poised To Accelerate
Earnings Expectations for the Week of October 15
Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)
Dr Faessel - 6-17-2011
Morgan Stanley Provided Color on Abbott Laboratories, Overweight
Wedbush Reports Solid Results But Fizzling Stocks For Abbott Labs
Morgan Stanley Maintains Overweight on Abbott Laboratories (ABT)
J.P. Morgan Lowers ABT Target To $55 From $60
Citigroup Lowers PT On Abbott Laboratories
Stocks Good for Guilty Holiday Diets
Goldman Sachs Decreases Price Target on Abbott Laboratories (ABT)
Abbott Laboratories' 3Q Preview
Rating: Buy Status Initiated for Abbott Laboratories (ABT)
Morgan Stanley's Equity Morning Summary